Citadel Advisors
TELA icon

Citadel Advisors’s TELA Bio TELA Stock Holding History

Citadel Advisors’s Portfolio TELA Stock Details TELA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-300
Closed -$366 – 15047
2025
Q1 		$366 Hold
300
– – ﹤0.01% 14277
2024
Q4 		$906 Buy
300
+200
+200% +$562 ﹤0.01% 14256
2024
Q3 		$253 Sell
100
-1,000
-91% -$3.56K ﹤0.01% 14065
2024
Q2 		$5.17K Sell
1,100
-200
-15% -$1.05K ﹤0.01% 13426
2024
Q1 		$7.37K Buy
+1,300
New +$8.57K ﹤0.01% 13617
2023
Q4 		– Sell
-200
Closed -$1.6K – 15249
2023
Q3 		$1.6K Sell
200
-200
-50% -$1.86K ﹤0.01% 13839
2023
Q2 		$4.05K Sell
400
-1,300
-76% -$13.3K ﹤0.01% 13635
2023
Q1 		$18.1K Buy
+1,700
New +$18.8K ﹤0.01% 13134

Other funds holding TELA

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Citadel Advisors's TELA Position: Q1 2026 in Review

Citadel Advisors sold out of TELA Bio (TELA) in Q1 2026, closing a stake of 23,382 shares — an estimated $27.6K sold.

Citadel Advisors first reported a position in TELA in Q1 2020 and held it in 13 quarters. The position peaked at $892K in Q2 2024. 36 funds tracked by Wall St. Rank hold TELA as of Q1 2026.

  • Citadel Advisors reported no remaining TELA Bio position as of Q1 2026 after selling out during the quarter.
  • Citadel Advisors sold 23,382 TELA Bio shares in Q1 2026, an estimated $27.6K.
  • Citadel Advisors first reported a position in TELA Bio in Q1 2020 and held it in 13 quarters.
  • Citadel Advisors's TELA Bio position peaked at $892K in Q2 2024.
  • 36 funds tracked by Wall St. Rank held TELA Bio as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.